Anti-DLL3 [SC16.15]

Absolute Antibody

Anti-DLL3 [SC16.15]

9

The binding characterization of this antibody to human DLL3 was done using ELISA. Binding affinity of mouse IgG antibody for human DLL3 is Kd= 0.2 nM. This antibody can bind human, cynomolgus monkey, rat and mouse DLL3 expressed on surface of 293 cells via flow cytometry. This antibody can mediate killing of tumor cells expressing DLL3 and facilitate the delivery of cytotoxic agents to live cells, in an vitro cell killing assay. This antibody was capable of killing OV26 cells, an ovarian NET NTX tumor, with a sub-picomolar EC50 (e.g. 0.14 pM). Humanized version of this antibody is also available on request. Human IgG1 version was capable of killing LU37 cells in an in vitro killing assay. This antibody was used for the generation of antibody-drug conjugates for suppressing tumor growth (US9089615). It was also used in combination with OKT3 for generation of a bispecific antibody targeting DLL3 and CD3. It was also used for the generation of DLL3-targeted CAR-T cells (PMID: 32554616).

Functional Assay, Flow Cytometry, ELISA

Research Use Only

Monoclonal

SC16.15

DLL3

delta like canonical Notch ligand 3

SCDO1, delta-like protein 3, delta-like 3, delta3, drosophila Delta homolog 3

Human

IgG1

Delta-like protein 3

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Human, Monkey, Mouse, Rat

-20°C,2°C to 8°C

12352203